Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-27 @ 3:09 PM
Study NCT ID:
NCT00496769
Status:
COMPLETED
Last Update Posted:
2018-06-15
First Post:
2007-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2010-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-25
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-02
First Submit QC Date:
None
Study First Post Date:
2007-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-01
Results First Submit QC Date:
None
Results First Post Date:
2013-11-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-02-27
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-05-16
Last Update Post Date:
2018-06-15
Last Update Post Date Type:
ACTUAL